Clinically feasible stratification of 1-year to 3-year post-myocardial infarction risk.

Horne, Benjamin D; Muhlestein, Joseph B; Bhandary, Durgesh; Hoetzer, Greta L; Khan, Naeem D; Bair, Tami L; Lappé, Donald L

Horne, Benjamin D; Muhlestein, Joseph B; Bhandary, Durgesh; Hoetzer, Greta L; Khan, Naeem D; Bair, Tami L; Lappé, Donald L.

Afiliação

Horne BD; Intermountain Heart Institute, Intermountain Medical Center, Salt Lake City, Utah, USA.
Muhlestein JB; Department of Biomedical Informatics, University of Utah, Salt Lake City, Utah, USA.
Bhandary D; Intermountain Heart Institute, Intermountain Medical Center, Salt Lake City, Utah, USA.
Hoetzer GL; Cardiology Division, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
Khan ND; AstraZeneca Pharmaceuticals LP, Wilmington, Delaware, USA.
Bair TL; AstraZeneca Pharmaceuticals LP, Wilmington, Delaware, USA.
Lappé DL; AstraZeneca Pharmaceuticals LP, Wilmington, Delaware, USA.

Open Heart ; 5(1): e000723, 2018.

Article em En | MEDLINE | ID: mdl-29531761

Palavras-chave

clinical decision tool; implementation science; learning healthcare system; precision medicine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google